Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20250809066791N1Phase 3Completed
Phase 3, open-label trial of ropivacaine, sufentanil, propofol, midazolam, atracurium and 1 more in hip fracture (2 arms), sponsored by Qazvin University of Medical Sciences. Primary endpoints: Incidence of severe intraoperative hypotension, Intraoperative norepinephrine intake and 2 more. Started Nov 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20250809066791N1.